Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study

Increased Plasma DPP4 Activity Is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study

(2014) Fan Yang et al.   PLoS One

Dipeptidyl peptidase-4: A key player in chronic liver disease

(2013) Minoru Itou   WORLD JOURNAL OF GASTROENTEROLOGY

Prevalence and associated factors of microalbuminuria in Chinese individuals without diabetes: cross-sectional study

(2013) Jianzhong Xiao et al.   BMJ Open

An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease

(2012) Jixin Zhong et al.   ATHEROSCLEROSIS

Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease

(2012) Ai-li Sun et al.   Diabetes & Vascular Disease Research

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

(2011) D. Lamers et al.   DIABETES

All-Cause Mortality Risk Among a National Sample of Individuals With Diabetes

(2010) K. M. Nelson et al.   DIABETES CARE

Prevalence of Diabetes among Men and Women in China

(2010) Wenying Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme

(2009) E. Matteucci et al.   CURRENT MEDICINAL CHEMISTRY

C-reactive protein and microalbuminuria in a multi-ethnic Asian population

(2009) C. Sabanayagam et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association of C-Reactive Protein and Microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004)

(2007) Abhijit V. Kshirsagar et al.   AMERICAN JOURNAL OF CARDIOLOGY